[1] |
NAM HC, SUNG PS, JUNG ES, et al. Solitary fibrous tumor of the liver mimicking malignancy[J]. Korean J Intern Med, 2020, 35(3): 734-735. DOI: 10.3904/kjim.2018.442.
|
[2] |
ANDALUZ GARCÍA I, TAVECCHIA M, OLVEIRA MARTÍN A. A solitary fibrous tumor: An entity to consider in the diagnosis of liver masses[J]. Rev Esp Enferm Dig, 2019, 111(12): 969. DOI: 10.17235/reed.2019.6433/2019.
|
[3] |
ROUY M, GUILBAUD T, BIRNBAUM DJ. Liver solitary fibrous tumor: A rare incidentaloma[J]. J Gastrointest Surg, 2021, 25(3): 852-853. DOI: 10.1007/s11605-020-04701-8.
|
[4] |
ALONSO BATANERO S, GARROSA MUÑOZ S, IGLESIAS IGLESIAS MJ, et al. A giant solitary fibrous tumor arising from the hepatic round ligament[J]. Dig Liver Dis, 2021, 53(3): 379-380. DOI: 10.1016/j.dld.2020.06.015.
|
[5] |
DU Y, YAN YH, XIAO JS, et al. Giant right hepatic benign fibroma: A case report and literature review[J]. Chin J Hepatobiliary Surg, 2019, 25(9): 701-702. DOI: 10.3760/cma.j.issn.1007-8118.2019.09.016.
杜源, 鄢业鸿, 肖建生, 等. 右肝巨大纤维瘤一例并文献复习[J]. 中华肝胆外科杂志, 2019, 25(9): 701-702. DOI: 10.3760/cma.j.issn.1007-8118.2019.09.016.
|
[6] |
MU YP, WANG RT, HOU HL, et al. Clinicopathological characteristics and surgical effcacy of liver solitary fibrous tumor and literature review[J/CD]. Chin J Hepat Surg (Electronic Edition), 2021, 10(1): 87-92. DOI: 10.3877/cma.j.issn.2095-3232.2021.01.019.
牟怡平, 王瑞涛, 侯惠莲, 等. 肝脏孤立性纤维瘤临床病理特征及手术疗效并文献复习[J/CD]. 中华肝脏外科手术学电子杂志, 2021, 10(1): 87-92. DOI: 10.3877/cma.j.issn.2095-3232.2021.01.019.
|
[7] |
FAMÀ F, LE BOUC Y, BARRANDE G, et al. Solitary fibrous tumour of the liver with IGF-Ⅱ-related hypoglycaemia. A case report[J]. Langenbecks Arch Surg, 2008, 393(4): 611-616. DOI: 10.1007/s00423-008-0329-z.
|
[8] |
VENNARECCI G, ETTORRE GM, GIOVANNELLI L, et al. Solitary fibrous tumor of the liver[J]. J Hepatobiliary Pancreat Surg, 2005, 12(4): 341-344. DOI: 10.1007/s00534-005-0993-0.
|
[9] |
DELVECCHIO A, DUDA L, CONTICCHIO M, et al. Doege-Potter syndrome by malignant solitary fibrous tumor of the liver: A case report and review of literature[J]. World J Gastrointest Surg, 2019, 11(8): 348-357. DOI: 10.4240/wjgs.v11.i8.348.
|
[10] |
SONG L, ZHANG W, ZHANG Y. (18)F-FDG PET/CT imaging of malignant hepatic solitary fibrous tumor[J]. Clin Nucl Med, 2014, 39(7): 662-664. DOI: 10.1097/RLU.0000000000000431.
|
[11] |
DOYLE LA, VIVERO M, FLETCHER CD, et al. Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics[J]. Mod Pathol, 2014, 27(3): 390-395. DOI: 10.1038/modpathol.2013.164.
|
[12] |
YOSHIDA A, TSUTA K, OHNO M, et al. STAT6 immunohistochemistry is helpful in the diagnosis of solitary fibrous tumors[J]. Am J Surg Pathol, 2014, 38(4): 552-559. DOI: 10.1097/PAS.0000000000000137.
|
[13] |
DEMICCO EG, HARMS PW, PATEL RM, et al. Extensive survey of STAT6 expression in a large series of mesenchymal tumors[J]. Am J Clin Pathol, 2015, 143(5): 672-682. DOI: 10.1309/AJCPN25NJTOUNPNF.
|
[14] |
O'NEILL AC, TIRUMANI SH, DO WS, et al. Metastatic patterns of solitary fibrous tumors: A single-institution experience[J]. AJR Am J Roentgenol, 2017, 208(1): 2-9. DOI: 10.2214/AJR.16.16662.
|
[15] |
EBATA T, SHIMOI T, BUN S, et al. Efficacy and safety of pazopanib for recurrent or metastatic solitary fibrous tumor[J]. Oncology, 2018, 94(6): 340-344. DOI: 10.1159/000486623.
|
[16] |
MARUZZO M, MARTIN-LIBERAL J, MESSIOU C, et al. Pazopanib as first line treatment for solitary fibrous tumours: The Royal Marsden Hospital experience[J]. Clin Sarcoma Res, 2015, 5: 5. DOI: 10.1186/s13569-015-0022-2.
|
[17] |
STACCHIOTTI S, TORTORETO M, BALDI GG, et al. Preclinical and clinical evidence of activity of pazopanib in solitary fibrous tumour[J]. Eur J Cancer, 2014, 50(17): 3021-3028. DOI: 10.1016/j.ejca.2014.09.004.
|